329 related articles for article (PubMed ID: 30873415)
1. Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction.
Zeng H; Chen JX
Front Cardiovasc Med; 2019; 6():15. PubMed ID: 30873415
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction.
Zeng H; Chen JX
J Cardiovasc Pharmacol; 2019 Oct; 74(4):315-323. PubMed ID: 31425381
[TBL] [Abstract][Full Text] [Related]
3. Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction.
He X; Zeng H; Chen ST; Roman RJ; Aschner JL; Didion S; Chen JX
J Mol Cell Cardiol; 2017 Nov; 112():104-113. PubMed ID: 28935506
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease.
He X; Zeng H; Chen JX
J Cell Physiol; 2019 Mar; 234(3):2252-2265. PubMed ID: 30132870
[TBL] [Abstract][Full Text] [Related]
5. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction.
Tona F; Montisci R; Iop L; Civieri G
Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251
[TBL] [Abstract][Full Text] [Related]
6. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
7. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
8. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
Frisk M; Le C; Shen X; Røe ÅT; Hou Y; Manfra O; Silva GJJ; van Hout I; Norden ES; Aronsen JM; Laasmaa M; Espe EKS; Zouein FA; Lambert RR; Dahl CP; Sjaastad I; Lunde IG; Coffey S; Cataliotti A; Gullestad L; Tønnessen T; Jones PP; Altara R; Louch WE
J Am Coll Cardiol; 2021 Feb; 77(4):405-419. PubMed ID: 33509397
[TBL] [Abstract][Full Text] [Related]
9. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
Paulus WJ; Dal Canto E
JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
[TBL] [Abstract][Full Text] [Related]
10. Coronary Microcirculation in Heart Failure with Preserved Systolic Function.
Vasiljevic Z; Krljanac G; Zdravkovic M; Lasica R; Trifunovic D; Asanin M
Curr Pharm Des; 2018; 24(25):2960-2966. PubMed ID: 29992878
[TBL] [Abstract][Full Text] [Related]
11. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.
Taqueti VR; Solomon SD; Shah AM; Desai AS; Groarke JD; Osborne MT; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF
Eur Heart J; 2018 Mar; 39(10):840-849. PubMed ID: 29293969
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?
Cornuault L; Rouault P; Duplàa C; Couffinhal T; Renault MA
Front Physiol; 2022; 13():906272. PubMed ID: 35874523
[TBL] [Abstract][Full Text] [Related]
13. Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice.
Su H; Zeng H; He X; Zhu SH; Chen JX
J Am Heart Assoc; 2020 Sep; 9(18):e017176. PubMed ID: 32865093
[TBL] [Abstract][Full Text] [Related]
14. Ablation of SIRT3 causes coronary microvascular dysfunction and impairs cardiac recovery post myocardial ischemia.
He X; Zeng H; Chen JX
Int J Cardiol; 2016 Jul; 215():349-57. PubMed ID: 27128560
[TBL] [Abstract][Full Text] [Related]
15. The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction.
Ovchinnikov AG; Arefieva TI; Potekhina AV; Filatova AY; Ageev FT; Boytsov SA
Acta Naturae; 2020; 12(2):40-51. PubMed ID: 32742726
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.
Shah SJ; Lam CSP; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Ljung Faxén U; Fermer ML; Broberg MA; Gan LM; Lund LH
Eur Heart J; 2018 Oct; 39(37):3439-3450. PubMed ID: 30165580
[TBL] [Abstract][Full Text] [Related]
17. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
Seferović PM; Paulus WJ
Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Yang JH; Obokata M; Reddy YNV; Redfield MM; Lerman A; Borlaug BA
Eur J Heart Fail; 2020 Mar; 22(3):432-441. PubMed ID: 31840366
[TBL] [Abstract][Full Text] [Related]
19. Heart failure with preserved ejection fraction in hypertension.
Teo LY; Chan LL; Lam CS
Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
[TBL] [Abstract][Full Text] [Related]
20. A Sex-Specific Role of Endothelial Sirtuin 3 on Blood Pressure and Diastolic Dysfunction in Female Mice.
Zeng H; He X; Chen JX
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
